LON:AZN
Bristol-Myers Squibb Company gained approximately 8% in premarket trade ahead of the start of regular U.S. trading, following news of initial discussions with AstraZeneca PLC.
Company hubLON:AZN
Follow the latest Bristol Myers (AZN) company news, earnings coverage and investor analysis from TechStock².
All coverage
AstraZeneca shares dropped roughly 5% on Monday following news of early-stage merger discussions. Bristol Myers gained approximately 6% ahead of the New York cash…
London stocks were up on Monday, though the bulk of initial gains faded shortly after the open. By 09:40 BST, the FTSE 100 was…
Energy could contribute roughly 62% of the anticipated growth in European earnings for the second quarter. With that early estimate, the FTSE 100’s performance…
